CYP24A1 and neoplasm: The series of 189 tumours with both components (carcinomas in situ and the corresponding invasive tumour) allowed the evaluation of the expression of the VDR, CYP27B1 and CYP24A1 simultaneously in the two types of tumours (Additional file 2: Table S2).